Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/103789
Title: Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment
Authors: Ferreira, Pedro L. 
Luzeiro, Isabel 
Lopes, Margarida
Jorge, André
Silva, Bruno
Ferreira, Lara
Keywords: Patient reported outcomes; Quality of life, Migraine; mMIDAS-P; Productivity, Disability
Issue Date: 6-Feb-2021
Publisher: Springer Nature
Project: Novartis Farma - research grant 
CEISUC/CIBB is funded by national funds through FCT - Foundation for Science and Technology, I.P., under the Multiannual Financing of R&D Units 2020–2023 
Serial title, monograph or event: BMC Neurology
Volume: 21
Issue: 1
Abstract: Background: Migraine Disability Assessment Scale (MIDAS) is a useful tool to measure headache-related disability. Modified MIDAS with 4-week recall period reduces recall bias and improves accuracy of the results. This study aimed at validating mMIDAS in Portuguese. Methods: Studied population consisted of adult migraine patients attending a headache outpatient clinic. Reliability was assessed by internal consistency and reproducibility in a 3-week test-retest. Content validity was evaluated by two expert panels. Construct validity was tested by comparing mMIDAS-P index in socioeconomic and clinical patient groups and scale unidimensionality was evidenced by factor analysis. Criterion validity was tested using EQ-5D-5L and HADS. Results: Ninety-two patients, 88% female, mean age of 44 years, participated. They had, in average, 9.7 headache days in previous month, pain averaging 7.5/10. About 69.9% were on a migraine prophylactic treatment, and 42.4% had severe disability; 29.4 and 13.0% showed, respectively, moderate/severe anxiety and depression. Content validity showed that mMIDAS-P is simple and clinically useful. It did not show to be determined by patient’s sociodemographic characteristics and it was correlated with depression scale and EQ-5D-5L. Test-retest demonstrated high reproductive reliability and good internal consistency. Conclusion: mMIDAS-P is valid and reliable. We strongly recommend it for clinical and research use.
URI: https://hdl.handle.net/10316/103789
ISSN: 1471-2377
DOI: 10.1186/s12883-021-02085-z
Rights: openAccess
Appears in Collections:I&D CEISUC - Artigos em Revistas Internacionais

Show full item record

SCOPUSTM   
Citations

2
checked on Apr 15, 2024

WEB OF SCIENCETM
Citations

2
checked on Apr 2, 2024

Page view(s)

50
checked on Apr 24, 2024

Download(s)

29
checked on Apr 24, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons